NASDAQ: MGRX
Mangoceuticals Inc Stock Ownership - Who owns Mangoceuticals?

Insider buying vs selling

Have Mangoceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MGRX insiders and whales buy or sell their stock.

MGRX Shareholders

What type of owners hold Mangoceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan Arango9.49%1,000,000$2.21MInsider
Jacob D. Cohen5.74%605,000$1.34MInsider
Vanguard Group Inc1.73%182,613$403.57kInstitution
Amanda Elizabeth Hammer1.66%175,000$386.75kInsider
Antonios Isaac0.57%60,000$132.60kInsider
Eugene M. Johnston0.36%38,334$84.72kInsider
Kenny Myers0.35%36,667$81.03kInsider
Lorraine Pamela Dalessio0.35%36,667$81.03kInsider
Ackerman Capital Advisors LLC0.33%34,500$76.25kInstitution
Renaissance Technologies LLC0.29%31,000$68.51kInstitution

1 of 2

MGRX vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGRX2.75%18.79%
ZCMD0.30%0.00%
HCTI22.75%77.25%
BFRG3.18%24.50%Net SellingNet Selling
VSEE1.13%64.08%Net Buying

Mangoceuticals Stock Ownership FAQ

Who owns Mangoceuticals?

Mangoceuticals (NASDAQ: MGRX) is owned by 2.75% institutional shareholders, 18.79% Mangoceuticals insiders, and 78.46% retail investors. Jonathan Arango is the largest individual Mangoceuticals shareholder, owning 1.00M shares representing 9.49% of the company. Jonathan Arango's Mangoceuticals shares are currently valued at $2.22M.

If you're new to stock investing, here's how to buy Mangoceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.